# FUJIFILM Cellular Dynamics to build $21M iPS cell production facility in Madison

FUJIFILM Cellular Dynamics, Inc. announced an investment of about $21 million to open a new cGMP-compliant production facility in Madison, Wisconsin, with the goal to begin operations by March 2020. The facility will support internal cell therapeutics and serve as a CDMO for iPS cell products.

- Type: New facility
- Announced: 2019-01-03
- Where: Madison, Wisconsin, United States
- Value: $21.0M
- Starts operating: Mar 2020
- Status: announced
- Products: human induced pluripotent stem (iPS) cells for regenerative medicine therapies
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [FUJIFILM Cellular Dynamics, Inc.](https://endata.com/companies/36474.md)
- [Fujifilm](https://endata.com/companies/5880.md) (partner)

## Sources

- [fujifilmcdi.com](https://www.fujifilmcdi.com/news-item/fujifilm-cellular-dynamics-to-establish-new-facility-for-production-of-human-ips-cell-therapy-applications), 2019-01-03: "To meet the growing demand for FCDI's iPS cell platform, the state-of-the-art production facility will have a flexible cell culturing design to serve production requirements of both industrial quantities of cells, and small, diverse batches."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.